Lv1
30 积分 2024-05-06 加入
Construction of a linker library with widely controllable flexibility for fusion protein design
5小时前
待确认
Fusion Proteins: Current Status and Future Perspectives
8小时前
已完结
Fusion Proteins: Current Status and Future Perspectives
8小时前
已关闭
Structural insights into the high-affinity IgE receptor FcεRI complex
1个月前
已完结
Efficacy of anifrolumab across organ domains in patients with moderate-to-severe systemic lupus erythematosus: a post-hoc analysis of pooled data from the TULIP-1 and TULIP-2 trials
3个月前
已完结
Effectiveness and safety of Belimumab and Telitacicept in systemic lupus erythematosus: a real-world, retrospective, observational study
3个月前
已完结
生物制剂在系统性红斑狼疮中应用的中国专家共识（2024版）
3个月前
已完结
Telitacicept: First Approval
3个月前
已完结
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
4个月前
已关闭
Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients
4个月前
已关闭
皖公网安备34019202002308
